MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.250
-0.020 (-0.88%)
At close: Jul 25, 2025, 4:00 PM
2.330
+0.080 (3.56%)
After-hours: Jul 25, 2025, 7:21 PM EDT
MaxCyte Stock Forecast
Stock Price Forecast
The 2 analysts that cover MaxCyte stock have a consensus rating of "Strong Buy" and an average price target of $7.5, which forecasts a 233.33% increase in the stock price over the next year. The lowest target is $6 and the highest is $9.
Price Target: $7.5 (+233.33%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MaxCyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +166.67% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +300.00% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +388.89% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +388.89% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +255.56% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
42.04M
from 38.63M
Increased by 8.82%
Revenue Next Year
50.91M
from 42.04M
Increased by 21.12%
EPS This Year
-0.39
from -0.39
EPS Next Year
-0.38
from -0.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.0M | 54.4M | 93.3M | ||
| Avg | 42.0M | 50.9M | 90.6M | ||
| Low | 39.7M | 45.1M | 87.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.9% | 29.4% | 83.3% | ||
| Avg | 8.8% | 21.1% | 78.0% | ||
| Low | 2.8% | 7.2% | 71.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.36 | -0.35 |
| Avg | -0.39 | -0.38 |
| Low | -0.41 | -0.39 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.